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Purpose of the study
The aim of the study was to characterize retrospectively
the group of patients (pts) with central nervous system
toxoplasmosis and AIDS.
Methods
Data were collected according to basic pts' profile, includ-
ing immunological status, ARV treatment, clinical presen-
tation of disease, treatment pattern and outcome: clinical
state and neuro-imaging results were taken into consider-
ation mainly. Autopsy examination, if performed, was
evaluated as well.
Summary of results
The examined group consisted of 40 pts hospitalized in
4th Department of Regional Hospital for Infectious Dis-
eases in Warsaw, between 1994 and 2007; 33 men and 7
women were included. Age ranged from 24 to 49 (average
34) years. 73% of patients had severe immunological def-
icit (CD4 + < 100 cells/mm3) when CNS toxoplasmosis
was diagnosed. Focal neurological deficiency, fever and
disturbances of attention and concentration were the
most frequent clinical signs of the disease (respectively,
71%, 68%, 65%). Neuro-imaging revealed single (56% in
CT) or multiple (70.6% in MRI) typical focal lesion/s with
peripheral enhancement with contrast (35% in CT, 77%
in MRI) and brain edema (63% in CT and 65% in MRI) in
most cases. Majority of pts (63%) were treated with sul-
fadiazine, pyrimetamine and folinic acid. In 14/27 (52%)
pts treated with sulfadiazine, adverse events complicated
therapy: allergic reaction 64%, nephrotoxicity 21%, neu-
tropenia 7%. Complete recovery was achieved in 38% of
pts; 18% pts died, the rest had some neurological compli-
cations as remnant: epilepsy 18%, hemiparesis 13%, cere-
bellar ataxia 5%. In the group of pts that died,
toxoplasmosis of CNS often co-existed with other neu-
ropathology as CMV infection of CNS (42%) or HIV
encephalitis (34%) which were revealed in autopsy exam-
inations. Most of pts that died of CNS toxoplasmosis
(57,9%) did not receive ARV treatment, in opposition to
all survivors. The secondary prophylaxis of CNS toxoplas-
mosis was broken by the relapse of the disease in two
(9%) cases. Six cases of CNS toxoplasmosis were devel-
oped despite the primary prophylaxis.
Conclusion
Most of our pts with CNS toxoplasmosis had severe
immunodeficiency. Pts in our group presented various
clinical signs of the disease. Neuro-imaging of CNS toxo-
plasmosis revealed mainly single in CT but multiple in
MRI focal lesions. Therapy with sulfadiazine was often
associated with side-effects. The prophylaxis of CNS toxo-
plasmosis can be insufficient in some cases.
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